Drug Type Interferons, Biosimilar |
Synonyms Interferon Alfa-2B Biosimilar(Fundação Oswaldo Cruz), 干扰素α-2B生物类似药(Fundação Oswaldo Cruz) |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BR (01 Jan 2006), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis B | BR | 01 Jan 2006 | |
Hepatitis C | BR | 01 Jan 2006 | |
Human Papillomavirus Infection | BR | 01 Jan 2006 | |
Kaposi Sarcoma | BR | 01 Jan 2006 | |
Melanoma | BR | 01 Jan 2006 | |
Philadelphia chromosome positive chronic myelogenous leukemia | BR | 01 Jan 2006 | |
Renal Cell Carcinoma | BR | 01 Jan 2006 |